Maze Therapeutics, Inc.
MAZE
$25.56
-$0.87-3.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 352.38M | 341.92M | 383.94M | 264.54M | 294.37M |
| Total Receivables | 21.80M | 1.50M | 700.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.60M | 6.30M | 6.67M | 6.61M | 5.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 379.78M | 349.72M | 391.30M | 271.15M | 299.71M |
|
|
|||||
| Total Current Assets | 379.78M | 349.72M | 391.30M | 271.15M | 299.71M |
| Net Property, Plant & Equipment | 23.97M | 25.16M | 26.46M | 27.71M | 28.80M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.41M | 4.14M | 4.30M | 4.66M | 4.34M |
| Total Assets | 419.71M | 397.13M | 422.06M | 303.52M | 332.84M |
|
|
|||||
| Total Accounts Payable | 4.01M | 1.79M | 2.92M | 3.67M | 2.40M |
| Total Accrued Expenses | 12.39M | 15.97M | 14.43M | 11.52M | 11.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.84M | 4.80M | 4.76M | 4.72M | 4.67M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.24M | 22.56M | 22.11M | 19.90M | 18.62M |
|
|
|||||
| Total Current Liabilities | 21.24M | 22.56M | 22.11M | 19.90M | 18.62M |
| Long-Term Debt | 38.83M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.55M | 18.51M | 19.42M | 20.29M | 21.15M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 388.00K | 1.09M | 1.09M | 1.09M | 1.01M |
| Total Liabilities | 78.01M | 42.16M | 42.62M | 41.28M | 40.77M |
|
|
|||||
| Common Stock & APIC | 855.59M | 844.40M | 834.35M | 687.13M | 683.28M |
| Retained Earnings | -513.76M | -489.55M | -454.98M | -424.89M | -391.21M |
| Treasury Stock & Other | -135.00K | 110.00K | 69.00K | -- | -- |
| Total Common Equity | 341.70M | 354.97M | 379.44M | 262.24M | 292.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 341.70M | 354.97M | 379.44M | 262.24M | 292.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 341.70M | 354.97M | 379.44M | 262.24M | 292.07M |
|
|
|||||